Email: cspc@cspc.cn
Media
News Center
Jun. 27
2023
VOLUNTARY ANNOUNCEMENT - NMPA ACCEPTANCE OF BIOLOGIC LICENSE APPLICATION OF OMALIZUMAB FOR INJECTION
Jun. 26
Strategic Cooperation between CSPC and China Unicom
CSPC Listed in TOP 50 Global Pharmaceutical Companies Again
Presentation of CSPC’s Research Achievements as a Special Report at the International Stroke Conference
CSPC Won the First Hebei Charity Award!
Jun. 25
CSPC Leading Top 100 in R&D Strength Again
Contact Us
Phone:
+86 311 8703 7015
Email:
cspc@cspc.cn
Products
Science
About Us
